Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mobia Medical is a medical device company developing a minimally invasive endoscopic solution for the treatment of metabolic diseases, including obesity and type 2 diabetes. The company's technology is designed to target the duodenum to alter metabolic signaling, aiming to achieve the clinical benefits of gastric bypass surgery without the associated surgical risks. By focusing on duodenal modulation, Mobia seeks to provide a scalable and effective intervention for patients struggling with glycemic control and weight management. Headquartered in Mountain View, California, the company is an alumnus of the Fogarty Innovation incubator.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mobia Medical.